Keurig Dr Pepper stock heads toward November 3 results

Published on 10/08/2026 at 02:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Keurig Dr Pepper stock heads toward November 3 results after adjusted Q2 EPS rose 16.3 percent to USD 0.57. Full-year sales guidance is USD 25.9 billion to USD 26.4 billion.

Geometrisches Bauhaus-Poster in Rot-Orange mit stilisiertem Getränkeglas und Schriftzug BEVERAGE — Bauhaus-Poster mit geometrischen Formen und Schriftzug BEVERAGE repräsentiert Branche von Keurig Dr Pepper US49271V1008, Illustration mit AI erstellt.

Keurig Dr Pepper stock (ISIN US49271V1008) was last at USD 31.13 on Nasdaq on October 6, 2026, up 0.78 percent. The company is now heading toward its next results date, with third-quarter figures scheduled for November 3, 2026, according to Keurig Dr Pepper on October 1, 2026.

Q2 sales reached USD 7.31 billion

Second-quarter 2026 net sales increased 74.6 percent to USD 7.31 billion, reflecting the JDE Peet's acquisition completed on April 1. Excluding that transaction, legacy Keurig Dr Pepper sales grew 7.3 percent, according to Benzinga in its Q2 transcript.

Adjusted diluted EPS increased 16.3 percent to USD 0.57. Adjusted operating income rose 42.9 percent, but U.S. Coffee operating income declined 24.7 percent as green coffee inflation, tariffs and higher marketing costs pressured the segment.

Guidance depends on coffee integration

Keurig Dr Pepper reaffirmed 2026 net sales guidance of USD 25.9 billion to USD 26.4 billion, including USD 8.5 billion to USD 8.7 billion from JDE Peet's. The company also maintained its outlook for low double-digit constant-currency adjusted EPS growth and USD 2.5 billion in full-year free cash flow, according to Benzinga.

The integration case carries a measurable target: management is pursuing USD 400 million in cost synergies from the JDE Peet's deal. For investors, the key tension is visible in the segment split, with strong refreshment beverages and JDE Peet's offsetting pressure in U.S. Coffee.

Analysts see room above USD 31.13

MarketBeat reported a Moderate Buy consensus from 19 analysts with an average price target of USD 34.94. The target lies 12.2 percent above the October 6 price of USD 31.13, while the stock's 52-week range runs from USD 24.88 to USD 33.82.

Wells Fargo analyst Christopher Carey maintained a Buy rating and a USD 37.00 target on October 5, 2026, as reported by Business Insider. That analyst view sits alongside the broader consensus rather than replacing it.

November 3 is the next checkpoint

Keurig Dr Pepper's market capitalization was USD 42.4 billion as of October 7, 2026, while its Nasdaq share price was last at USD 31.13 on October 6. The November 3 results will test whether integration benefits can offset the coffee segment's cost pressure.